Ex vivo modelling of drug efficacy in a rare metastatic urachal carcinoma

BACKGROUND: Ex vivo drug screening refers to the out-of-body assessment of drug efficacy in patient derived vital tumor cells. The purpose of these methods is to enable functional testing of patient specific efficacy of anti-cancer therapeutics and personalized treatment strategies. Such approaches...

Descripción completa

Detalles Bibliográficos
Autores principales: Mäkelä, Rami, Arjonen, Antti, Härmä, Ville, Rintanen, Nina, Paasonen, Lauri, Paprotka, Tobias, Rönsch, Kerstin, Kuopio, Teijo, Kononen, Juha, Rantala, Juha K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7313172/
https://www.ncbi.nlm.nih.gov/pubmed/32576176
http://dx.doi.org/10.1186/s12885-020-07092-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7313172/
https://www.ncbi.nlm.nih.gov/pubmed/32576176
http://dx.doi.org/10.1186/s12885-020-07092-w

Ejemplares similares